MT-II acts as a non-selective agonist at melanocortin receptors (MC1R, MC3R, MC4R, MC5R), with its most extensively studied effect being the stimulation of melanogenesis the biological process by which melanin pigment is produced in skin and hair follicles
Gyurkocza B, Plescia J, Raskett CM, Garlick DS, Lowry PA, Carter BZ, Andreeff M , Meli M, Colombo G, Altieri DC
Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation Journal of Molecular Medicine (Berlin, Germany), 2017 Mar, Volume 95 (Issue 3), Pages 323-333
Since Im uncomfy around needles, that means injectables like Botox and fillers are out of the pictureat least for now